[1] Hanna DL, Lenz HJ.How we treat left-sided vs right-sided colon cancer[J]. Clin Adv Hematol Oncol, 2020, 18(5): 253-257. [2] Abedizadeh R, Majidi F, Khorasani HR, et al.Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments[J]. Cancer Metastasis Rev, 2024, 43(2): 729-753. [3] 魏鹏宇,李杨,高加勒,等.经肛全直肠系膜切除治疗直肠癌十年回顾与展望[J].外科研究与新技术,2023,12(1):1-6. [4] Altintas S, Bayrak M.Assessment of factors influencing lymph node count in colorectal cancer[J]. J Coll Physicians Surg Pak, 2019, 29(12): 1173-1178. [5] Bufill JA.Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location[J]. Ann Intern Med, 1990, 113(10): 779-788. [6] Torun M, Uzun O, Duman M, et al.Comparison of oncological outcomes after curative resection for right-side colon cancer and left-side colon cancer: a retrospective observational study[J]. Turk J Colorectal Dis, 2024, 34(4):123-129. [7] Li Y, Feng Y, Dai W, et al.Prognostic effect of tumor sidedness in colorectal cancer: a SEER-based analysis[J]. Clin Colorectal Cancer, 2019, 18(1): e104-e116. [8] Kuliavas J, Marcinkevičiūtė K, Baušys A, et al.Short-and long-term outcome differences between patients undergoing left and right colon cancer surgery: cohort study[J]. Int J Colorectal Dis, 2024, 39(1): 66-74. [9] Gourdin G, Chotel L, de la Fouchardière C. BRAF V600E metastatic colorectal cancer: perspective from a patient, a caregiver, and an oncologist[J]. Adv Ther, 2023, 40(8): 3281-3290. [10] Missiaglia E, Jacobs B, D’Ario G, et al. Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features[J]. Ann Oncol, 2014, 25(10): 1995-2001. [11] Brouwer NPM, Erdogan ASO, van Vliet S, et al. Unraveling the routes to distant metastases in colorectal cancer: tumor deposits and lymph node metastases as the gateway[J]. Cancer Commun (Lond), 2024, 44(10): 1209-1213. [12] Zhang Q, Xu R, Zhen W, et al.Competing risk and random survival forest models for predicting survival in post-resection elderly stage Ⅰ-Ⅲ colorectal cancer patients[J]. Sci Rep, 2025, 15(1): 24269-24287. [13] Weiser MR.AJCC 8th edition: colorectal cancer[J]. Ann Surg Oncol, 2018, 25(6): 1454-1455. [14] Overman MJ, McDermott R, Leach JL, et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study[J]. Lancet Oncol, 2017, 18(9): 1182-1191. |